COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,696 Articles (22,913 medRxiv, 8,783 bioRxiv)

Most recent first Previous |  Page 677: Articles 6761-6770  | Next

The impact of access to financial services on mitigating COVID-19 mortality globally
Watkins, T. A., Nguyen, K., Ali, H., Gummakonda, R., Pelman, J., Taracena, B.
10.1101/2022.09.12.22279872 — Posted: 2022-09-16
Rationale, Design, and Baseline Characteristics of the VALIANT (COVID-19 in Older Adults: A Longitudinal Assessment) Cohort
Cohen, A. B., McAvay, G., Geda, M., Chattopadhyay, S., Lee, S., Acampora, D., Araujo, K., Charpentier, P., Gill, T. M., Hajduk, A., Ferrante, L.
10.1101/2022.09.14.22279932 — Posted: 2022-09-15
Evaluation of long-term sequelae by cardiopulmonary exercise testing 12 months after hospitalization for critical COVID-19
Noureddine, S., Roux, P., Laurent, L., Ritter, O., Dolla, P., Karaer, S., Claude, F., Westeel, V., Barnig, C.
10.1101/2022.09.12.22279779 — Posted: 2022-09-15
A Cross-Sectional Study of Quantitative CT Measurements Associated with the Diffusion Capacity of the Lung in Recovered COVID-19 Patients with Clear Chest CTs
Wen, H., Kanth, S. M., Huapaya Carrera, J. A., Sun, J., Do, M., Chen, M. Y., Malayeri, A. A., Suffredini, A. F.
10.1101/2022.09.13.22279543 — Posted: 2022-09-15
Severe fatigue as symptom of long COVID is characterized by increased expression of inflammatory genes in monocytes, increased serum pro-inflammatory cytokines, and increased CD8+ T-lymphocytes. A putative dysregulation of the immune-brain axis, the coagulation process, and auto-inflammation to explain the diversity of long COVID symptoms
Berentschot, J. C., Drexhage, H. A., Aynekulu Mersha, D. A., Wijkhuijs, A. J., GeurtsvanKessel, C. H., Koopmans, M. P., Voermans, J., Heijenbrok-Kal, M. H., Bek, L. M., Ribbers, G. M., van den Berg-Emons, R. J., Aerts, J. G., Dik, W. A., Hellemons, M. E.
10.1101/2022.09.15.22279970 — Posted: 2022-09-15
Mind The Gap: Data availability, accessibility, transparency, and credibility during the COVID-19 pandemic, an international comparative appraisal
Rotulo, A., Kondilis, E., Thwe, T., Gautam, S., Torcu, O., Vera-Montoya, M., Marjan, S., Gazi, M. I., Putri, A. S., Hasan, R. B., Mone, F. H., Rodriguez-Castillo, K., Tabassum, A., Parcharidi, Z., Sharma, B., Islam, F., Amoo, B., Lemke, L., Gallo, V.
10.1101/2022.09.14.22279961 — Posted: 2022-09-15
What is the effectiveness of financial support schemes for individuals requested to self-isolate following a positive Covid test or positive contact: A rapid review
Winfield, T., Elston, L., Washington, J., Hasler, E., Lewis, R., Cooper, A., Edwards, A. G.
10.1101/2022.09.15.22279969 — Posted: 2022-09-15
O-Linked Sialoglycans Modulate the Proteolysis of SARS-CoV-2 Spike and Contribute to the Mutational Trajectory in Variants of Concern
Gonzalez-Rodriguez, E., Zol-Hanlon, M., Bineva-Todd, G., Marchesi, A., Skehel, M., Mahoney, K., Roustan, C., Borg, A., Di Vagno, L., Kjaer, S., Wrobel, A. G., Benton, D. J., Nawrath, P., Flitsch, S. L., Joshi, D., Gonzalez-Ramirez, A. M., Wilkinson, K. A., Wilkinson, R. J., Hurtado-Guerrero, R., Malaker, S. A., Schumann, B.
10.1101/2022.09.15.508093 — Posted: 2022-09-15
A hybrid structure determination approach to investigate the druggability of the nucleocapsid protein of SARS-CoV-2
Padroni, G., Bikaki, M., Novakovic, M., Wolter, A. C., Ruedisser, S. H., Gossert, A. D., Leitner, A., Allain, F. H.- T.
10.1101/2022.09.15.507991 — Posted: 2022-09-15
Fast bioluminescent nucleic acid detection using one-pot isothermal amplification and dCas9-based split luciferase complementation
van der Veer, H. J., van Aalen, E. A., Michielsen, C. M. S., Hanckmann, E. T. L., Deckers, J., van Borren, M. M. G. J., Flipse, J., Loonen, A. J. M., Schoeber, J. P. H., Merkx, M.
10.1101/2022.09.12.507659 — Posted: 2022-09-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).